Amplifying the Patient Voice: Reflections from MAPS EMEA 2025
At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the patient voice is central to every stage of the drug development journey, a theme eloquently showcased in the Opening General Assembly: Patient Impact on Medical Affairs. Global leaders in Medical Affairs gathered to explore how the industry can evolve from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
The Quest for Omnichannel: Is Medical Affairs Ready?
Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication
Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...
A Guide to Creating a Robust Patient Engagement Strategy
Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive...
Which Regulatory Requirements Are Applicable to “Legacy” Devices?
Understanding the requirements for your medical device is vital in today’s market. But are these...
Ensuring Alignment Across EU MDR Deliverables
How to avoid all these pitfalls and keep thriving in the EU Medical Devices market?...
Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR
The latest EU-MDR guidelines are a step in the right direction, moving from a focus...